MarketPeel
Insider Trading Intelligence
HL

Hongbo Lu

TERN
DIRECTOR · TERNS PHARMACEUTICALS, INC. · CIK 0001767584
FILING MIX · LIFETIME97%/3%
BUYS
29
SELLS
1
TOTAL VALUE
$33.12M
COMPANIES
3
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
115,512
AVG SELL PX
$76.88
TRADE KIND
SHOWING 30 / 30
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Hongbo Lu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+90.00%+8.57%+0.90%+7.67%+3.45%
14d10+50.00%+2.43%+2.36%+0.06%-3.61%
30d10+30.00%-3.79%+1.88%-5.67%-13.56%
60d10+20.00%+0.67%+3.84%-1.96%-13.58%
90d10+20.00%-11.82%+7.76%-19.58%-22.39%
180d10(3 pending)+14.29%-36.03%+3.80%-39.83%-35.87%
1y10(4 pending)+16.67%-28.91%+14.45%-43.36%-49.00%
2y10(7 pending)+100.00%+102.23%+28.79%+73.43%+73.84%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TERN · 45,000 shares · as of Jun 11, 2025
01,085,0532,170,1063,255,1594,340,2122022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 1 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 15, 2026Jun 17, 2026View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,970$76.88$228.3K52,012May 12, 2026May 14, 2026View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
75,000$20.00$1.50M422,968Mar 31, 2026Mar 31, 2026View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
3,768$18.63$70.2K426,736Mar 31, 2026Apr 2, 2026View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
25,985$22.50$584.7K347,968Feb 11, 2026Feb 13, 2026View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,81954,982Dec 16, 2025Dec 18, 2025View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
263,160$19.00$5.00M321,983Oct 7, 2025Oct 9, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 11, 2025Jun 12, 2025View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 10, 2025Jun 12, 2025View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,65710,657Feb 1, 2025Feb 3, 2025View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,733$22.99$384.7K47,163Dec 18, 2024Dec 20, 2024View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
58,823$17.00$1000.0K58,823Sep 13, 2024Oct 9, 2025View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASE
58,823$17.00$1000.0K58,823Sep 13, 2024Sep 17, 2024View →
ZBIO
ZENAS BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
37,00037,000Sep 12, 2024Sep 16, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
285,714$10.50$3.00M476,190Sep 12, 2024Sep 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
190,476$10.50$2.00M190,476Sep 12, 2024Sep 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,6764,676Jul 1, 2024Jul 2, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 10, 2024Jun 14, 2024View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASE
1,000$27.50$27.5K33,680Mar 20, 2024Mar 20, 2024View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASE
1,000$28.00$28.0K32,680Mar 19, 2024Mar 20, 2024View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASE
1,000$27.49$27.5K31,680Mar 18, 2024Mar 20, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 12, 2023Jun 14, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
758,620$7.25$5.50M4,340,212Dec 23, 2022Dec 23, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
600,000$3.60$2.16M3,581,592Sep 7, 2022Sep 8, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M2,981,592Aug 16, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M1,500,000Aug 16, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,218$2.99$3.6K1,481,592Aug 15, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,123,021$2.98$3.35M1,480,374Aug 12, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 16, 2022Jun 21, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Feb 24, 2021Feb 26, 2021View →
Other insiders · TERN
Loading peer insiders…
About this filer
CIK 0001767584
ROLE
Director
PRIMARY
TERN
COMPANIES
3
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001767584DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback